Literature DB >> 12960217

Identification of eight novel VEGFR-3 mutations in families with primary congenital lymphoedema.

A L Evans, R Bell, G Brice, P Comeglio, C Lipede, S Jeffery, P Mortimer, M Sarfarazi, A H Child.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12960217      PMCID： PMC1735587          DOI： 10.1136/jmg.40.9.697

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  13 in total

1.  Possible genetic predisposition to lymphedema after breast cancer.

Authors:  Beth Newman; Felicity Lose; Mary-Anne Kedda; Mathias Francois; Kaltin Ferguson; Monika Janda; Patsy Yates; Amanda B Spurdle; Sandra C Hayes
Journal:  Lymphat Res Biol       Date:  2012-03-09       Impact factor: 2.589

2.  VEGF-C alters barrier function of cultured lymphatic endothelial cells through a VEGFR-3-dependent mechanism.

Authors:  Jerome W Breslin; Sarah Y Yuan; Mack H Wu
Journal:  Lymphat Res Biol       Date:  2007       Impact factor: 2.589

Review 3.  From germline towards somatic mutations in the pathophysiology of vascular anomalies.

Authors:  Nisha Limaye; Laurence M Boon; Miikka Vikkula
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

4.  Familial congenital non-immune hydrops, chylothorax, and pulmonary lymphangiectasia.

Authors:  David A Stevenson; Theodore J Pysher; Robert M Ward; John C Carey
Journal:  Am J Med Genet A       Date:  2006-02-15       Impact factor: 2.802

5.  AIP1 mediates vascular endothelial cell growth factor receptor-3-dependent angiogenic and lymphangiogenic responses.

Authors:  Huanjiao Jenny Zhou; Xiaodong Chen; Qunhua Huang; Renjing Liu; Haifeng Zhang; Yingdi Wang; Yu Jin; Xiaoling Liang; Lin Lu; Zhe Xu; Wang Min
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-09       Impact factor: 8.311

Review 6.  Milroy disease and the VEGFR-3 mutation phenotype.

Authors:  G Brice; A H Child; A Evans; R Bell; S Mansour; K Burnand; M Sarfarazi; S Jeffery; P Mortimer
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

7.  Wide clinical spectrum in a family with hereditary lymphedema type I due to a novel missense mutation in VEGFR3.

Authors:  Ronen Spiegel; Arash Ghalamkarpour; Etty Daniel-Spiegel; Miikka Vikkula; Stavit A Shalev
Journal:  J Hum Genet       Date:  2006-08-19       Impact factor: 3.172

8.  CCM3 Loss-Induced Lymphatic Defect Is Mediated by the Augmented VEGFR3-ERK1/2 Signaling.

Authors:  Lingfeng Qin; Haifeng Zhang; Busu Li; Quan Jiang; Francesc Lopez; Wang Min; Jenny Huanjiao Zhou
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-10-21       Impact factor: 8.311

9.  Mutations in the VEGFR3 signaling pathway explain 36% of familial lymphedema.

Authors:  A Mendola; M J Schlögel; A Ghalamkarpour; A Irrthum; H L Nguyen; E Fastré; A Bygum; C van der Vleuten; C Fagerberg; E Baselga; I Quere; J B Mulliken; L M Boon; P Brouillard; M Vikkula
Journal:  Mol Syndromol       Date:  2013-08-21

10.  Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas.

Authors:  F C Connell; P Ostergaard; C Carver; G Brice; N Williams; S Mansour; P S Mortimer; Steve Jeffery
Journal:  Hum Genet       Date:  2008-11-12       Impact factor: 4.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.